HLA-Bw4-I-80 Isoform Differentially Influences Clinical Outcome As Compared to HLA-Bw4-T-80 and HLA-A-Bw4 Isoforms in Rituximab or Dinutuximab-Based Cancer Immunotherapy

Killer-cell immunoglobulin-like receptors (KIRs) are a family of glycoproteins expressed primarily on natural killer cells that can regulate their function. Inhibitory KIRs recognize MHC class I molecules (KIR-ligands) as ligands. We have reported associations of KIRs and KIR-ligands for patients in...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Front Immunol
Hlavní autoři: Erbe, Amy K., Wang, Wei, Reville, Patrick K., Carmichael, Lakeesha, Kim, KyungMann, Mendonca, Eneida A., Song, Yiqiang, Hank, Jacquelyn A., London, Wendy B., Naranjo, Arlene, Hong, Fangxin, Hogarty, Michael D., Maris, John M., Park, Julie R., Ozkaynak, M. F., Miller, Jeffrey S., Gilman, Andrew L., Kahl, Brad, Yu, Alice L., Sondel, Paul M.
Médium: Artigo
Jazyk:Inglês
Vydáno: Frontiers Media S.A. 2017
Témata:
Immunology
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5466980/
https://ncbi.nlm.nih.gov/pubmed/28659916
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2017.00675
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky